report banner

News in English

PostBlog Post
KT-seminar-The_Promise_of_Regenerqtion_Medicine_and_AI-Fb_bannernew

CERN seminar: The Promise of Regenerative Medicine and AI

During this seminar, Peter Egelberg, Founder of PHI, will present the work carried out by PHI in the development of time-lapse cytometry instrumentation and software.
Learn more …
PostNews
Swiss-based Altium major investor BioStock

BioStock: PHI catches eye of major investor

BioStock contacted Altium’s CEO Goran Dubravcic to learn more about their incentives to invest in PHI.
Learn more …
PostNews: Press Release

Swiss-based Altium acquires major stake in PHI

PHI announces that Altium S.A. recently acquired Formue Nord’s entire holdings in PHI of 2 416 679 shares and 1 491 362 TO 3 warrants and committed to exercise the obtained warrants.
Learn more …
PostNews
Patrik Eschricht and Peter Egelberg shaking hands

BioStock: PHI comments on the new senior positions in the company

BioStock reached out to Patrik Eschricht and Peter Egelberg to better understand the background behind the recent management shift.
Learn more …
PostNews: Press Release

PHI expands its global network to India

PHI has entered a business relationship with Medi Analytika India Pvt. Ltd. This new distributor will represent PHI in the large and growing Indian market and manage the full sales process and customer relations for the HoloMonitor® product portfolio.
Learn more …
PostNews: Press Release

PHI Focuses on Biomanufacturing — Appoints New CEO and Chairman

The Board of Directors of PHI has appointed the company’s CFO, Patrik Eschricht, as the new CEO. In addition, the former CEO and founder of PHI, Peter Egelberg, has been appointed executive chairman of the Board.
Learn more …
1234526